Drug Use clinical trials at UCSF

2 research studies open to eligible people

Drug use involves taking substances that affect the mind and body. UCSF is researching a treatment to help people who smoke both tobacco and cannabis. UCSF is also testing if text messages can help young people decrease their drug use.

Showing trials for

  • N-Acetylcysteine for Smoking Cessation in Tobacco and Cannabis Co-Use

    open to eligible people ages 18 years and up

    Tobacco and cannabis co-use is a common and growing public health problem, especially in states that have legalized cannabis. There are no pharmacologic treatments for co-occurring tobacco and cannabis use. Co-use may make quitting either substance more difficult, given the synergistic effects of cannabis and nicotine on neurobiological systems that mediate reward and shared cues reinforcing co-use. N-acetylcysteine (NAC), an FDA-approved medication and over-the-counter supplement, has shown promise in animal studies and randomized controlled trials (RCTs) in reducing tobacco and cannabis craving and use.

    San Francisco, California

  • Technology to Reduce Youth Substance Use

    open to eligible people ages 13-18

    The research project will focus on conducting a trial of whether a tailored SMS text-messaging intervention is efficacious in improving justice-involved youths' substance use or dual diagnosis treatment attendance and engagement.

    San Francisco, California